Summary & Overview
HCPCS Level II C9898: Inpatient Radiolabeled Product
HCPCS Level II code C9898 represents the supply of a radiolabeled product provided during a hospital inpatient stay. Radiolabeled products are used for diagnostic imaging and targeted therapies; their use in the inpatient setting has implications for hospital billing, pharmacy handling, and inpatient clinical workflows. Nationally, accurate coding of inpatient radiopharmaceuticals affects hospital charges, payer adjudication, and downstream quality and utilization metrics.
This analysis covers major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an explanation of what C9898 captures clinically, a summary of typical payer coverage considerations, and context about how this inpatient supply code integrates with inpatient service lines. The publication outlines benchmarks and common billing practices where available, highlights policy and reimbursement topics relevant to inpatient radiolabeled products, and provides concise clinical context useful for billing staff, hospital revenue officers, and policy analysts.
Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code C9898 denotes a radiolabeled product provided during a hospital inpatient stay. This code is used to report the provision of a radiopharmaceutical or radiolabeled therapeutic agent that is administered to an inpatient as part of diagnostic imaging, therapy, or procedural care.
-
Service type: Inpatient radiolabeled product administration
-
Typical site of service: Hospital inpatient setting
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult inpatient admitted to a hospital for suspected or known malignancy who requires an in-hospital nuclear medicine therapeutic or diagnostic radiopharmaceutical during the admission. For example, a 64-year-old patient admitted for symptomatic metastatic thyroid cancer receives an intravenous dose of radioactive iodine as part of inpatient treatment. The clinical workflow includes inpatient order entry by the attending physician, pre-procedure nursing assessment and consent, coordination with the hospital radiopharmacy for preparation of the radiolabeled product, transport to the inpatient nuclear medicine or designated isolation room, administration by a nuclear medicine technologist or authorized clinician, post-administration monitoring for acute reactions, and documentation of the product lot, dose, route, and patient condition in the medical record. Billing of C9898 reflects the radiolabeled product provided during the hospital inpatient stay and is submitted with the inpatient claim, along with procedure, service, and diagnosis codes that justify use of the radiopharmaceutical.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When billing separates the physician professional interpretation from facility technical services for diagnostic nuclear medicine studies. |